OM vs TLRY · rev $113.7M vs rev $821.3M
Outset Medical Inc (OM) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Outset Medical Inc (OM) is a medical devices company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported OM revenue for 2024-12-31 was $113.7M. Net income was -$128.0M. Revenue was down 12.8% from 2023-12-31 to 2024-12-31. OM currently screens at market cap $74.5M.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
OM currently screens at market cap $74.5M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the OM and TLRY stock pages for the full models.
Not investment advice.